Abstract:BACKGROUND/AIMS:Macrophage inflammatory protein-2 (MIP-2), a type of leukocyte chemokine, is primarily produced by macrophages, and levels increase significantly in early inflammation. However, the precise biological functions and mechanisms of MIP-2 in the development of inflammation remain unclear. The purposes of the present study were to investigate the role of MIP-2 in inflammation induced by lipopolysaccharide (LPS) in vitro and to determine the possibility of blocking the high mobility group box 1 (HMGB1) signalling pathway via MIP-2 inhibition.METHODS:Macrophage cells (RAW264.7, U937 and THP-1 cells) were divided into control and treatments groups. Expression levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α), HMGB1, chemokine (C-C motif) ligand-2 (Ccl-2), Toll-like receptor-4 (TLR-4), inducible nitric oxide synthase (iNOS), phosphorylated MAPKs (p38, ERKs, JNKs), PI3K/Akts, JAKs/STAT3, IκB, and cytoplasmic and nuclear NF-κB p65 in RAW264.7 cells were detected by qRT-PCR, enzyme-linked immunosorbent assay (ELISA) or western blot assays.RESULTS:mip-2 siRNA and an anti-MIP-2 antibody significantly reduced the expression levels of Ccl-2, TLR-4, iNOS, IL-6, IL-1β, HMGB1, and TNF-α in RAW264.7 cells exposed to LPS (P<0.01). Additionally, mRNA expression levels of HMGB1 and TLR-4 in cells treated with LPS+mip-2 siRNA were significantly lower than those in cells treated with LPS alone (P<0.01 or P<0.05). The MIP-2 antibody significantly suppressed activation of p38-MAPK, p-STAT3, and p-Akts and translocation of NF-κB p65 from the cytoplasm to the nucleus in RAW264.7 exposed to LPS (P<0.01 or P<0.05).CONCLUSION:mip-2 siRNA and the MIP-2 antibody can reduce the inflammatory effects induced by LPS in macrophage cells. The mechanisms may occur through down-regulation of p38-MAPK, STAT3 and Akts phosphorylation and translocation of NF-κB p65. MIP-2 plays an important role in inflammation induced by LPS.

Azamollugin, a mollugin derivative, has inhibitory activity on MyD88- and TRIF-dependent pathways

Mollugin Inhibits the Inflammatory Response in Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Blocking the Janus Kinase-Signal Transducers and Activators of Transcription Signaling Pathway

Oxomollugin, an oxidized substance in mollugin, inhibited LPS-induced NF-κB activation via the suppressive effects on essential activation factors of TLR4 signaling

Inducible Microrna-223 Down-Regulation Promotes Tlr-Triggered Il-6 And Il-1 Beta Production In Macrophages By Targeting Stat3

Short-term Use of MyD88 Inhibitor TJ-M2010-5 Prevents D-Galactosamine/lipopolysaccharide-induced Acute Liver Injury in Mice.

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase

Toll-like Receptor 2 (Tlr2)-Dependent-positive and TLR2-independent-negative Regulation of Proinflammatory Cytokines by Mycobacterial Lipomannans.

LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing

MicroRNA-149 Negatively Regulates TLR-triggered Inflammatory Response in Macrophages by Targeting MyD88.

Myeloid Differentiation Protein 2 Silencing Decreases LPS-induced Cytokine Production and TLR4/MyD88 Pathway Activity in Alveolar Macrophages.

MyD88 As a Target of Microrna-203 in Regulation of Lipopolysaccharide or Bacille Calmette-Guerin Induced Inflammatory Response of Macrophage RAW264.7 Cells

Inhibition of Macrophage Migration Inhibitory Factor (MIF) Tautomerase Activity Suppresses Microglia‐mediated Inflammatory Responses

Incomplete Knockdown of MyD88 Inhibits LPS-Induced Lung Injury and Lung Fibrosis in a Mouse Model.

TLR3-Dependent Activation of TLR2 Endogenous Ligands Via the MyD88 Signaling Pathway Augments the Innate Immune Response

Impact of Mygalin on Inflammatory Response Induced by Toll-like Receptor 2 Agonists and IFN-γ Activation

A novel molluscan TLR molecule engaged in inflammatory response through MyD88 adapter recruitment

Inhibition of Interleukin-12 P40 Transcription and NF-κB Activation by Nitric Oxide in Murine Macrophages and Dendritic Cells*

MD-2 Regulates LPS-induced NLRP3 Inflammasome Activation and IL-1beta Secretion by a MyD88/NF-κB-dependent Pathway in Alveolar Macrophages Cell Line.

Macrophage Inflammatory Protein-2 in High Mobility Group Box 1 Secretion of Macrophage Cells Exposed to Lipopolysaccharide.

Ctenopharyngodon Idella Tollip Regulates MyD88-induced NF-κB Activation.